Author:
Hochhaus Günther,Chen Mong-Jen,Kurumaddali Abhinav,Schilling Uta,Jiao Yuanyuan,Drescher Stefanie K.,Amini Elham,Berger Simon M.,Kandala Bhargava,Tabulov Christine,Shao Jie,Seay Brandon,Abu-Hasan Mutasim N.,Baumstein Sandra M.,Winner Lawrence,Shur Jagdeep,Price Robert,Hindle Michael,Wei Xiangyin,Carrasco Cynthia,Sandell Dennis,Oguntimein Oluwamurewa,Kinjo Minori,Delvadia Renishkumar,Saluja Bhawana,Lee Sau L.,Conti Denise S.,Bulitta Jürgen B.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Draft guidance on Fluticasone Propionate; Salmeterol Xinofoate. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2013.
2. Draft guidance on formoterol fumarate; mometasone furoate. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2016.
3. Draft guidance on beclomethasone dipropionate; mometasone furoate. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2018.
4. Masoli M, Weatherall M, Holt S, Beasley R. Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child. 2004;89(10):902–7.
5. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med. 1998;157(3 Pt 2):S1–53.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献